PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
91.94%
Revenue growth above 1.5x ON's 1.59%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
122.82%
Gross profit growth 1.25-1.5x ON's 87.85%. Bruce Berkowitz would see if strategic sourcing or brand premium explains outperformance.
188.14%
EBIT growth 1.25-1.5x ON's 138.01%. Bruce Berkowitz would verify if strategic initiatives are driving this edge.
188.14%
Operating income growth 1.25-1.5x ON's 133.71%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
560.71%
Net income growth above 1.5x ON's 135.03%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
589.13%
EPS growth above 1.5x ON's 135.65%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
589.13%
Diluted EPS growth above 1.5x ON's 135.65%. David Dodd would see if there's a robust moat protecting these shareholder gains.
0.32%
Slight or no buybacks while ON is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
3.74%
Slight or no buyback while ON is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
-0.32%
Dividend reduction while ON stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-54.39%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-88.70%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
43.31%
10Y revenue/share CAGR at 50-75% of ON's 71.75%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
-15.35%
Negative 5Y CAGR while ON stands at 19.72%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-11.62%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
No Data
No Data available this quarter, please select a different quarter.
2204.86%
5Y OCF/share CAGR above 1.5x ON's 17.99%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-32.61%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
39.09%
Below 50% of ON's 245.86%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
104.35%
Below 50% of ON's 12132.26%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
-7.92%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
40.90%
Below 50% of ON's 142.72%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
63.10%
3Y equity/share CAGR 1.25-1.5x ON's 54.30%. Bruce Berkowitz confirms timely buybacks or margin improvements drive stronger near-term equity growth.
101.36%
Dividend/share CAGR of 101.36% while ON is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-22.01%
Negative 5Y dividend/share CAGR while ON stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
80.04%
3Y dividend/share CAGR of 80.04% while ON is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
-5.56%
Firm’s AR is declining while ON shows 12.36%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-5.69%
Inventory is declining while ON stands at 0.43%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.04%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
3.01%
BV/share growth above 1.5x ON's 0.51%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
No Data
No Data available this quarter, please select a different quarter.
20.71%
We increase R&D while ON cuts. John Neff sees a short-term profit drag but a potential lead in future innovations.
8.55%
SG&A growth well above ON's 1.18%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.